As per clopidogrel's MOA, what effects are experienced by the body?
Prevented ADP-stimulated platelet aggregation.
Irreversibly antagonizing the Gi P2Y12 receptor (which would normally lead to decreased cAMP and thus platelet aggregation), results in increased levels of cAMP and thus decreased platelet aggregation.